164 related articles for article (PubMed ID: 25993660)
21. SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway.
Ma J; Huang X; Xu J; Li Z; Lai J; Shen Y; Zhao J; Sun X; Ma L
Mol Med; 2023 Sep; 29(1):121. PubMed ID: 37684566
[TBL] [Abstract][Full Text] [Related]
22. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.
Li T; Yang W; Li M; Byun DS; Tong C; Nasser S; Zhuang M; Arango D; Mariadason JM; Augenlicht LH
Mol Nutr Food Res; 2008 Nov; 52(11):1289-99. PubMed ID: 18435490
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy.
Quinn DI; Henshall SM; Head DR; Golovsky D; Wilson JD; Brenner PC; Turner JJ; Delprado W; Finlayson JF; Stricker PD; Grygiel JJ; Sutherland RL
Cancer Res; 2000 Mar; 60(6):1585-94. PubMed ID: 10749127
[TBL] [Abstract][Full Text] [Related]
24. Altered expression of selenium-binding protein 1 in gastric carcinoma and precursor lesions.
Zhang J; Zhan N; Dong WG
Med Oncol; 2011 Dec; 28(4):951-7. PubMed ID: 20480265
[TBL] [Abstract][Full Text] [Related]
25. Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer.
Becker F; Joerg V; Hupe MC; Roth D; Krupar R; Lubczyk V; Kuefer R; Sailer V; Duensing S; Kirfel J; Merseburger AS; Brägelmann J; Perner S; Offermann A
Int J Cancer; 2020 Jan; 146(2):577-588. PubMed ID: 31271443
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts.
Pohl NM; Tong C; Fang W; Bi X; Li T; Yang W
PLoS One; 2009 Nov; 4(11):e7774. PubMed ID: 19924303
[TBL] [Abstract][Full Text] [Related]
27. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas.
Chen G; Wang H; Miller CT; Thomas DG; Gharib TG; Misek DE; Giordano TJ; Orringer MB; Hanash SM; Beer DG
J Pathol; 2004 Mar; 202(3):321-9. PubMed ID: 14991897
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
Kahl P; Gullotti L; Heukamp LC; Wolf S; Friedrichs N; Vorreuther R; Solleder G; Bastian PJ; Ellinger J; Metzger E; Schüle R; Buettner R
Cancer Res; 2006 Dec; 66(23):11341-7. PubMed ID: 17145880
[TBL] [Abstract][Full Text] [Related]
29. Selenoproteins of the Human Prostate: Unusual Properties and Role in Cancer Etiology.
Diamond AM
Biol Trace Elem Res; 2019 Nov; 192(1):51-59. PubMed ID: 31300958
[TBL] [Abstract][Full Text] [Related]
30. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.
Tsourlakis MC; Weigand P; Grupp K; Kluth M; Steurer S; Schlomm T; Graefen M; Huland H; Salomon G; Steuber T; Wilczak W; Sirma H; Simon R; Sauter G; Minner S; Quaas A
Am J Pathol; 2014 Mar; 184(3):609-17. PubMed ID: 24378408
[TBL] [Abstract][Full Text] [Related]
31. Role of SELENBP1 and SELENOF in prostate cancer bioenergetics.
Bera S; Diamond AM
Arch Biochem Biophys; 2022 Dec; 732():109451. PubMed ID: 36334799
[TBL] [Abstract][Full Text] [Related]
32. Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.
Li R; Erdamar S; Dai H; Wheeler TM; Frolov A; Scardino PT; Thompson TC; Ayala GE
Hum Pathol; 2007 Oct; 38(10):1501-7. PubMed ID: 17597184
[TBL] [Abstract][Full Text] [Related]
33. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
[TBL] [Abstract][Full Text] [Related]
34. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage.
Thomas GV; Schrage MI; Rosenfelt L; Kim JH; Salur G; deKernion JB; Dorey F; Said J; Reiter RE
J Urol; 2000 Dec; 164(6):1987-91. PubMed ID: 11061897
[TBL] [Abstract][Full Text] [Related]
35. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
Cao W; Li F; Yao J; Yu J
BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
[TBL] [Abstract][Full Text] [Related]
37. Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.
Horvath LG; Henshall SM; Lee CS; Kench JG; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
Int J Cancer; 2005 Jan; 113(3):415-22. PubMed ID: 15455387
[TBL] [Abstract][Full Text] [Related]
38. PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.
Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
[TBL] [Abstract][Full Text] [Related]
39. Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy.
Chen WY; Hua KT; Lee WJ; Lin YW; Liu YN; Chen CL; Wen YC; Chien MH
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455254
[TBL] [Abstract][Full Text] [Related]
40. DNA Methylation of miR-122 Aggravates Oxidative Stress in Colitis Targeting SELENBP1 Partially by p65NF-
Bai J; Yu J; Wang J; Xue B; He N; Tian Y; Yang L; Wang Y; Wang Y; Tang Q
Oxid Med Cell Longev; 2019; 2019():5294105. PubMed ID: 31019652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
